Legend Biotech (LEGN) Amortizatization of Intangibles (2020 - 2025)

Legend Biotech (LEGN) has reported Amortizatization of Intangibles for 6 consecutive years, with $100000.0 the latest figure, recorded in Q2 2025.

• Quarterly Amortizatization of Intangibles fell 72.68% year-over-year to $100000.0 in Q2 2025, while the trailing twelve-month figure through Jun 2025 was $908000.0 (down 59.32% YoY) and the FY2024 annual result came in at $1.9 million, changed 0.36% from the prior year.
• Amortizatization of Intangibles fell to $100000.0 in Q2 2025 per LEGN's latest filing, from $128000.0 in the prior quarter.
• Over the last five years, Amortizatization of Intangibles for LEGN reached as high as $885000.0 in Q1 2024 and fell as low as $100000.0 in Q2 2025.
• A 5-year average of $441000.0 and a median of $392500.0 in 2021 frame the typical range for Amortizatization of Intangibles.
• Annual changes were most pronounced in 2021 — Amortizatization of Intangibles jumped 1451.85% — and 2025, when it plunged 85.54%.
• Year by year, Amortizatization of Intangibles stood at $419000.0 in 2021, then soared by 104.06% to $855000.0 in 2022, then sank by 43.63% to $482000.0 in 2023, then fell by 24.07% to $366000.0 in 2024, then plunged by 72.68% to $100000.0 in 2025.
• According to Business Quant data, Amortizatization of Intangibles over the past three periods registered $100000.0, $128000.0, and $366000.0 for Q2 2025, Q1 2025, and Q4 2024 respectively.